Tumor associated antigens in human renal cell carcinoma: MHC restricted recognition by cytotoxic T lymphocytes
Authors:
- 1 July 1996
- journal article
- Published by Wiley in Tissue Antigens
- Vol. 48 (1) , 22-31
Abstract
Based on previous studies in human melanoma leading to the molecular cloning of genes encoding peptide antigens recognized by MHC‐restricted cytotoxic T lymphocytes (CTL) we extended our efforts to renal cancer systems established in tissue culture. In two patients we obtained stable CD8+ CTL clones with high cytolytic activity for the corresponding autologous tumor cell line in vitro. Neither autologous EBV‐transformed B lymphocytes or PHA‐activated PBL nor natural killer targets K562 were lysed by these CTL clones. MZ1257‐RCC CTL5‐30 lysed autologous tumor cells as well as normal kidney cell cultures in an HLA‐A2 restricted fashion. Further specificity analysis showed cross reactivity with HLA‐A2 matched renal cancer cell lines, melanoma cell lines and tumor cell lines of other origins. HLA‐A2 negative target cells were not lysed. The restriction element for T cell recognition in another renal cancer system, MZ1973‐RCC, appeared to be HLA‐B8 as tested with CTL 5–10. Crossreactivity of CTL 5–10 was documented with one HLA‐B8 positive RCC line. Tumor cell lines of other origin were not lysed by CTL 5–10. For further study of CTL‐defined epitopes, peptides were extracted from tumor cell lines. Peptides from cultured cell lines were acid‐eluted and fractionated by reversed phase HPLC. The peptide fractions were tested in cytotoxicity assays for their ability to reconstitute RCC epitopes by addition to the HLA‐A2. 1 positive antigen processing mutant cell line 721.124xCEM.T2. One HPLC peak was identified containing an epitope for the HLA‐A2 restricted MZ1257‐RCC CTL 5–30. These peptide epitopes were present in the autologous renal cancer cell line MZ1257‐RCC as well as in an allogeneic HLA‐A2 positive RCC cell line MZ1973 and melanoma cell line SK29‐MEL, but were absent in peptides eluted from autologous EBV‐B cells. We conclude that renal cell carcinoma may induce autologous CTL. Epitopes recognized by MHC‐restricted CTL on RCC may be shared by HLA‐matched allogeneic renal cancer or even tumors of other origin, such as melanoma. The current challenge is the determination of the amino acid sequences of these CTL‐defined peptides as a step to further characterize the nature of these tumor associated antigens.Keywords
This publication has 29 references indexed in Scilit:
- Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell LinesScience, 1994
- Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.Journal of Experimental Medicine, 1993
- Immunologic recognition of malignant melanoma by autologous T lymphocytesCurrent Opinion in Oncology, 1993
- Characterization of a Human Renal Cell Carcinoma Specific Cytotoxic CD8+ T Cell LineJournal of Immunotherapy, 1992
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytesNature, 1989
- Presence on a human melanoma of multiple antigens recognized by autologous CTLInternational Journal of Cancer, 1989
- Tumor‐Infiltrating Lymphocytes in Patients with Renal‐Cell CarcinomaAnnals of the New York Academy of Sciences, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17Human Immunology, 1980